Hormone Optimization
Lose weight quickly with science
- Lose up to 22.5% of your body weight 1
- Feel full faster and stay full longer 2
- Starting at $499.99 per month
Active ingredients
Tirzepatide is a dual GIP and GLP-1 receptor agonist. This means, in addition to mimicking the effects of GLP-1, it also mimics the effects of the GIP (glucose-dependent insulinotropic polypeptide) hormone. The combined action on both receptors provides additional benefits for weight loss.
GLP-1s work on key underlying metabolic pathways to support sustained weight loss, rather than a quick fix. You'll lose the weight quickly.
Benefits:
- Weight Loss
- Appetite
Ingredients in Weight Loss Protocol are prescribed off-label.
Learn about 'off-label uses'.
Lose weight from home
Complete an online in-take form. Measure your hormone levels with an accurate at-home device. Consult with your doctor. Begin treatment – all from the comfort of your home.
You have questions, we have answers.
Who is eligible for treatment?
A GLP-1 agonist might be for you if you need an adjuvant for lifestyle modifications in losing weight or controlling metabolic parameters, like blood glucose. If you have a BMI of over 25 and a comorbidity associated with your weight, you are an eligible candidate for treatment.
Is this compounded with base form or salt form?
This protocol is compounded with base form.
What states is Weight Loss Protocol available in?
Maximus currently serves all US States, except Alabama, Alaska, Arizona, California, Indiana, Michigan, North Carolina, and the District of Columbia. Maximus does not serve US Territories and Freely Associated States at this time.
We are expanding as quickly as possible. In the meantime, sign up for our newsletter to get updates and gain access to our free E-Book and Discord community. You can sign up by visiting Testosterone 101 or scrolling to the bottom of this page and providing your email.
If I have been previously prescribed GLP-1, can I start at that dosage with Maximus?
If you have documentation of previous GLP-1 agonist usage, our providers will work with you to find an optimal dose that matches your profile.
Will I be on this product for life?
GLP1 agonists are designed to complement a healthy diet and regular exercise regimen. While these lifestyle choices are generally long-term commitments, the duration of use for this product isn't necessarily indefinite. It's crucial to have ongoing discussions with your healthcare provider about the appropriateness and duration of use for this product tailored to your individual needs.
Which treatment option is best for me, semaglutide or tirzepatide?
Both semaglutide and tirzepatide have been shown to be extremely effective in helping patients lose weight. Semaglutide has been shown to help patients lose 14.9% of body weight over 68 weeks (2.4mg once per week), while tirzepatide has been shown to help patients lose 20.9% of body weight over 72 weeks (15mg once per week).
For those seeking the more affordable option, we recommend semaglutide. For those seeking the most effective treatment, we recommend tirzepatide
Wilding, John P.H., Rachel L. Batterham, Salvatore Calanna, Melanie Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara M. McGowan, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine 384, no. 11 (March 18, 2021): 989–1002. https://doi.org/10.1056/NEJMoa2032183 .
Jastreboff, Ania M., Louis J. Aronne, Nadia N. Ahmad, Sean Wharton, Lisa Connery, Breno Alves, Arihiro Kiyosue, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine 387, no. 3 (July 21, 2022): 205–16. https://doi.org/10.1056/NEJMoa2206038.
How much weight, specifically, can I expect to lose?
Combined with dietary changes and exercise, patients can expect to lose an average of 22.5%.
How long until I see results?
Your results are contingent upon adherence to diet and exercise. Appetite suppression and craving reduction starts shortly after beginning the medication. Noticeable results in weight loss start within the first few weeks after the medication reaches a steady state dosage.
Is there any harm in injecting myself? Is there a best place to inject?
Most GLP-1 agonists are administered safely as subcutaneous injections, meaning they are injected into the fatty layer of tissue just under the skin. The best places for these injections are typically the abdomen, thighs, or upper arms, where there is sufficient fatty tissue. Always rotate the injection site each time to avoid skin issues. Practice proper hygiene, injection techniques, and safety measures.
Does the protocol have adverse side effects?
The adverse effects of semaglutide and tirzepatide have been extensively studies in placebo-controlled clinical trials. The drugs are generally well-tolerated, however, infrequent and transient, dose-related side effects may occur.
Nausea: 12%
Diarrhea: 12%
Decreased Appetite: 5%
Vomiting: 5%
Constipation: 6%
Dyspepsia: 8%
Abdominal Pain: 6%
Can I switch from Tirzepatide to Semaglutide?
Unfortunately, once you begin treatment with Tirzepatide you cannot switch to Semaglutide seamlessly. Although both medications are in the same class, how you react to them may differ. As a result, switching medications will require you to begin at the lowest dose and titrate upwards in strength to determine how your body will react to the drug.
Can I use this product as a woman?
Yes – Tirzepatide is available to both men and women.
We hold ourselves to the highest scientific standards — here are our sources.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What is Maximus?
Maximus provides a technology platform that enables members access to board-certified, licensed physicians who may prescribe medications, where medically necessary and clinically appropriate.
Protocols typically include:
- Prescription (if appropriate)
- Physician visit, monitoring, optimization
- Result tools to track progress
